Beacon RNA Cited in Nature’s NPJ Genomic Medicine Journal

Beacon RNA, a leading RNA therapeutics database, has been cited in a recent publication by Jones et al, in Nature’s NPJ Genomic Medicine Journal (DOI: 10.1038/s41525-023-00387-4). The study highlights the role Beacon RNA can play in advancing RNA-based research, underscoring its value in precision medicine and genetic investigations.

RNA therapeutics have rapidly evolved from a promising concept to a transformative force in healthcare, driven by advances in genetic engineering and delivery systems. This publication explored the future of RNA medical products, emphasizing the need for innovative thinking and policy shifts to maximize their potential.

The authors utilized Beacon RNA to identify the number of pre-clinical and active clinical RNA programs, by RNA class, and the mRNA pipeline by therapeutic area. By leveraging the platform’s extensive RNA therapeutic database, the study was able to gain valuable insight into the RNA drug development landscape, facilitating novel insights into RNA classes and therapeutic targets.

RNA has the potential to revolutionize drug development across various therapeutic areas. As the industry evolves, RNA is expected to disrupt traditional approaches and become a fundamental pillar of modern medicine.

What is Beacon RNA?

Beacon RNA is the most comprehensive RNA therapeutics database available. Providing timely and accurate, market leading, pre-clinical and clinical RNA drug, trial, and commercial intelligence data.

  • Unrivalled comprehensive & accurate pre-clinical and clinical RNA therapeutic drug, trial and commercial data.
  • Access to >4,500 Drugs, >2,000 Trials, >2,500 Companies, and >2,500 Deals in the RNA Therapeutic space
  • Market leading ontologies, enabling precise navigation of specific RNA therapeutics
  • Manually curated by RNA scientists, with data updated daily
  • Your one stop shop for RNA therapeutic intelligence data

Learn More About Beacon RNA